Women Affair: Pharma firm recalls 2 lots of birth control pills over low ascorbic acid, impurity

*Lupin Pharmaceuticals, based in Maryland, United States, is recalling two lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets) over low ascorbic acid and a high level of ‘known impurity’

Emmanuel Akosile | ConsumerConnect

Lupin Pharmaceuticals is recalling two lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets).

ConsumerConnect gathered the company said one lot of the birth control pills tested low for ascorbic acid (an inactive ingredient) and high for a known impurity.

The pharmaceutical firm also noted there have been no reports of adverse events this far.

However, Lupin Pharmaceuticals stated if there were a significant reduction in the amount of ascorbic acid, this could potentially affect the effectiveness of the product which could potentially result in unexpected pregnancy.

A list of the lots of the product, packaged in 28’s blister and distributed nationwide to wholesalers, drug chains, mail order pharmacies and supermarkets, may be found here.

In regard to do in addressing low ascorbic acid in the two affected lots of the birth control pills, it is suggested that patients taking Tydemy should continue taking their medication, and immediately contact their pharmacist, physician, or medical provider for advice regarding “an alternative treatment”.

Consumers with questions may contact Inmar Rx Solutions, Inc. on (866) 480-8206 Monday – Friday 09:00 a.m. to 05:00 p.m. (EST).

Reimbursement for affected consumers

For reimbursement, the company said consumers must have the recalled lots returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the carton, report said.